Compare Mizuho Financial Group Inc. Sponosred ADR (Japan) (MFG) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mizuho Financial Group Inc. Sponosred ADR (Japan) vs Relay Therapeutics Inc. Common Stock — how do they compare? Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.59 (market cap $127.85B), while Relay Therapeutics Inc. Common Stock trades at $18.27 (market cap $3.82B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 33.5× Relay Therapeutics Inc. Common Stock's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.72% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mizuho Financial Group Inc. Sponosred ADR (Japan) for 1 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| MFG | RLAY | |
|---|---|---|
Market Cap | $127.85B | $3.82B |
Volume | 3,950,750 | 4,332,079 |
Sector | Financials | Health |
52-Week High | $11.45 | $20.75 |
52-Week Low | $6.09 | $6.03 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $35.14T | $2.93B |
Dividend Yield | 1.72% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Mizuho Financial Group Inc. Sponosred ADR (Japan)
Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
